Knowledge

4DMedical

Source đź“ť

29: 424:
and high sensitivity scanning. It can be used as an X-ray device, a 3D CT scanner, and a 4D CT scanner. The scanner technology can significantly decrease the number of animals required for experiments, as individual time points no longer require the sacrifice of groups of animals for a readout of lung
423:
imaging system that can quantify regional changes in pulmonary function. It was built for researchers and is compatible with XV Technology. As a small animal diagnostic tool, researchers can use the technology to develop novel therapeutics and new drug compounds. The scanner offers high resolution
410:
to develop the world's first dedicated lung function scanner, XV Scanner. The XV Scanner uses XV Technology to deliver dynamic, detailed, and quantitative lung function measurements to clinicians. The capability to quantify a patient's regional lung function improves management of lung conditions.
370:
Computed Tomography Lung Ventilation Analysis Software (CT LVAS) provides a non-invasive assessment of regional lung motion and airflow. It provides data to generate detailed maps of both the patterns of lung motion and pulmonary function, with functional deficits detected through local (regional)
229:
cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the
285:
and advanced visualization to generate high-resolution images of the motion of, and airflow through, lung tissue. XV Technology research has been documented in over 100 peer-reviewed publications and over 72 patents and patent applications.
343:. It provides data to generate detailed maps of both the patterns of lung motion and pulmonary function, with functional deficits detected through local (regional) differences in movement. The XV LVAS report analyzes the lungs in 224:
equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the
706: 560: 691: 411:
The XV Scanner overcomes differs from existing lung diagnostic and imaging tools by providing low-dose contrast-free, rapid lung analysis for adults and children.
306:
and other toxic substances. 4DMedical has worked closely with advocacy groups such as Burn Pits 360 on difficult-to-diagnose lung diseases in exposed US military
273:, Australia) to develop the underlying technology behind 4DMedical's XV Technology. In 2005 Fouras conceptualized 4D imaging using X-rays and in 2009, the first 382:
CT images (one at the inspiratory phase and one at expiratory phase) as the input. CT LVAS uses existing hardware and integrates into clinical workflows.
701: 686: 696: 298:(Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022) was signed into U.S. law in 2022, and expands 656: 610: 371:
differences in movement. The CT LVAS report analyzes the lungs in three dimensions (3D), between two phases of the breath at breath hold.
402:
4DMedical's wholly owned subsidiary, Australian Lung Health Initiative (ALHI), received AUD$ 28.9 million in funding from the
466: 632: 311: 339:
X-ray Velocimetry Lung Ventilation Analysis Software (XV LVAS) is a non-invasive assessment of regional lung motion and
586: 386: 359: 247: 64: 295: 611:"4DMedical Receives TGA Approval For XV Lung Ventilation Analysis Software (XV LVAS) | BioMelbourne Network" 209:, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report. 403: 355: 246:
Founded in 2013, 4DMedical commenced business as 4DX, started as a private company and listed on the
344: 127: 487: 348: 319: 254: 217: 299: 187: 8: 420: 107: 458: 446: 226: 462: 315: 266: 235: 454: 407: 511: 302:(VA) healthcare and benefits for previously deployed veterans who were exposed to 347:(3D) over time, during multiple phases of tidal (normal) breathing, resulting in 47: 354:
XV LVAS was released to market after receiving regulatory clearance by the US
281:
imaging techniques used by engineers to develop a new technique that combines
68: 680: 289: 55: 561:"Vanderbilt Completes Evaluation of Four-Dimensional Lung Imaging Software" 419:
The Permetium, a small animal scanner, is the first commercially dedicated
198: 176:
is a medical technology company, based in Australia and the United States.
28: 375: 323: 282: 278: 183: 262: 425: 385:
CT LVAS was released to the market in Australia after listing on the
270: 194: 277:
for XV Technology was filed. Fouras and his colleagues adapted
186:
Lung Ventilation Analysis Software (XV LVAS) based on the company's
303: 253:
Prior to founding 4DMedical, Dr. Andreas Fouras was a professor of
257:, and worked closely with the researchers from the Departments of 340: 307: 258: 231: 221: 202: 147:
CT LVAS (Computed Tomography Lung Ventilation Analysis Software)
379: 274: 205:(CT) images. Airflow is measured throughout all regions of the 191: 234:. Thus, treatment may be applied early to increase impact and 144:
XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software)
213: 180: 404:
Australian Federal Government's Medical Research Future Fund
535: 358:
in May 2020 and released in Australia after listing on the
206: 657:"$ 28.9M MRFF grant revolutionises lung function scanning" 290:
PACT Act and Lung Disease in Veterans Exposed to Burn Pits
488:"4DMedical Intellectual Property | Patents | Trade Marks" 220:(SaaS) model, where patients are scanned using existing 162: 707:
Companies listed on the Australian Securities Exchange
378:
technology that processes and analyzes non-contrast
633:"4DMedical (ASX:4DX) releases CT LVAS in Australia" 587:"US FDA clears 4DMedical's lung imaging technology" 512:"Publications | Clinical & Preclinical Studies" 445:Karapapa, Stavroula; McDonagh, Luke (2019-05-13), 692:Medical technology companies of the United States 318:have indicated a correlation in findings between 678: 444: 414: 453:, Oxford University Press, pp. 209–230, 702:Manufacturing companies based in Melbourne 201:research to process and enhance X-ray and 27: 687:Medical technology companies of Australia 697:Australian companies established in 2013 630: 584: 679: 16:Australian medical technology company 392: 329: 312:Vanderbilt University Medical Center 13: 190:XV Technology. XV Technology uses 14: 718: 661:Newsroom | University of Adelaide 459:10.1093/he/9780198747697.003.0009 565:Medical Design & Development 250:Ltd. (ASX: 4DX) in August 2020. 631:Durrani, Desiree (2022-10-25). 649: 624: 603: 578: 553: 528: 504: 480: 438: 248:Australian Securities Exchange 1: 431: 415:Permetium Preclinical Scanner 397: 7: 406:(MRFF) Frontier Health and 91:; 11 years ago 10: 723: 365: 334: 322:XV LVAS lung analysis and 241: 451:Intellectual Property Law 310:. Ongoing studies at the 157: 137: 114: 103: 85: 77: 53: 43: 35: 26: 216:its XV Technology via a 591:Medical Device Network 585:ajohney (2020-05-26). 255:Biomedical Engineering 197:adapted from advanced 218:Software as a Service 351:(4D) measurements. 203:Computed Tomography 108:Melbourne, Victoria 23: 324:open lung biopsies 314:and the Nashville 179:4DMedical created 81:Medical Technology 21: 637:The Market Herald 468:978-0-19-874769-7 393:Hardware products 330:Software products 267:Monash University 171: 170: 714: 671: 670: 668: 667: 653: 647: 646: 644: 643: 628: 622: 621: 619: 618: 607: 601: 600: 598: 597: 582: 576: 575: 573: 572: 557: 551: 550: 548: 547: 532: 526: 525: 523: 522: 508: 502: 501: 499: 498: 484: 478: 477: 476: 475: 447:"9. Trade marks" 442: 408:Medical Research 349:four-dimensional 345:three dimensions 167: 164: 99: 97: 92: 31: 24: 20: 722: 721: 717: 716: 715: 713: 712: 711: 677: 676: 675: 674: 665: 663: 655: 654: 650: 641: 639: 629: 625: 616: 614: 609: 608: 604: 595: 593: 583: 579: 570: 568: 559: 558: 554: 545: 543: 534: 533: 529: 520: 518: 510: 509: 505: 496: 494: 486: 485: 481: 473: 471: 469: 443: 439: 434: 417: 400: 395: 368: 337: 332: 300:Veteran Affairs 292: 244: 161: 153: 133: 117: 95: 93: 90: 73: 58: 22:4DMedical, Ltd. 17: 12: 11: 5: 720: 710: 709: 704: 699: 694: 689: 673: 672: 648: 623: 602: 577: 552: 527: 503: 479: 467: 436: 435: 433: 430: 416: 413: 399: 396: 394: 391: 367: 364: 336: 333: 331: 328: 291: 288: 243: 240: 214:commercialized 212:4DMedical has 169: 168: 159: 155: 154: 152: 151: 148: 145: 141: 139: 135: 134: 132: 131: 124: 123:Andreas Fouras 120: 118: 115: 112: 111: 105: 101: 100: 87: 83: 82: 79: 75: 74: 72: 71: 61: 59: 54: 51: 50: 45: 41: 40: 37: 33: 32: 15: 9: 6: 4: 3: 2: 719: 708: 705: 703: 700: 698: 695: 693: 690: 688: 685: 684: 682: 662: 658: 652: 638: 634: 627: 612: 606: 592: 588: 581: 566: 562: 556: 541: 537: 536:"burnpits360" 531: 517: 513: 507: 493: 489: 483: 470: 464: 460: 456: 452: 448: 441: 437: 429: 427: 422: 412: 409: 405: 390: 388: 383: 381: 377: 372: 363: 361: 357: 352: 350: 346: 342: 327: 325: 321: 317: 313: 309: 305: 301: 297: 287: 284: 280: 276: 272: 268: 264: 260: 256: 251: 249: 239: 237: 233: 228: 223: 219: 215: 210: 208: 204: 200: 196: 193: 189: 185: 182: 177: 175: 166: 160: 156: 149: 146: 143: 142: 140: 136: 129: 125: 122: 121: 119: 113: 109: 106: 102: 88: 84: 80: 76: 70: 66: 63: 62: 60: 57: 52: 49: 46: 42: 38: 34: 30: 25: 19: 664:. Retrieved 660: 651: 640:. Retrieved 636: 626: 615:. Retrieved 613:. 2020-10-08 605: 594:. Retrieved 590: 580: 569:. Retrieved 567:. 2022-09-01 564: 555: 544:. Retrieved 542:. 2023-08-22 539: 530: 519:. Retrieved 515: 506: 495:. Retrieved 491: 482: 472:, retrieved 450: 440: 418: 401: 384: 373: 369: 353: 338: 320:non-invasive 293: 252: 245: 211: 199:aerodynamics 178: 173: 172: 104:Headquarters 44:Company type 18: 540:burnpits360 421:preclinical 376:cloud-based 283:fluoroscopy 279:wind-tunnel 227:respiratory 188:proprietary 184:Velocimetry 110:, Australia 681:Categories 666:2023-09-01 642:2023-09-01 617:2023-09-01 596:2023-09-01 571:2023-09-01 546:2023-09-01 521:2023-09-01 497:2023-09-01 474:2023-09-01 432:References 398:XV Scanner 263:Physiology 195:algorithms 150:XV Scanner 116:Key people 516:4DMedical 492:4DMedical 426:pathology 389:in 2022. 362:in 2021. 304:burn pits 271:Melbourne 174:4DMedical 163:4dmedical 56:Traded as 380:thoracic 374:It is a 308:veterans 296:PACT Act 236:outcomes 192:patented 138:Products 78:Industry 36:Formerly 366:CT LVAS 341:airflow 335:XV LVAS 259:Physics 242:History 232:disease 222:imaging 158:Website 94: ( 86:Founded 67::  465:  275:patent 48:Public 181:X-ray 463:ISBN 387:ARTG 360:ARTG 316:VAMC 294:The 261:and 207:lung 165:.com 96:2013 89:2013 455:doi 356:FDA 265:at 128:CEO 69:4DX 65:ASX 39:4Dx 683:: 659:. 635:. 589:. 563:. 538:. 514:. 490:. 461:, 449:, 428:. 326:. 238:. 669:. 645:. 620:. 599:. 574:. 549:. 524:. 500:. 457:: 269:( 130:) 126:( 98:)

Index


Public
Traded as
ASX
4DX
Melbourne, Victoria
CEO
4dmedical.com
X-ray
Velocimetry
proprietary
patented
algorithms
aerodynamics
Computed Tomography
lung
commercialized
Software as a Service
imaging
respiratory
disease
outcomes
Australian Securities Exchange
Biomedical Engineering
Physics
Physiology
Monash University
Melbourne
patent
wind-tunnel

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑